BKBo Gun Kho

Bo Gun Kho

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Bo Gun Kho has a total of 57 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Short-Term Smoking Cessation Is Associated With Improved Metabolic Profiles in Young Male Soldiers

    byĀ Joon-Young Yoon, Sanghoon Lee, Chang-Seok Yoon, Bo-Gun Kho, Tae-Ok Kim, Yong-Soo Kwon, Yu-Il Kim, Sung-Chul Lim, Hong-Joon Shin

    Yoon JY, et al. J Korean Med Sci. 2027 Feb;42:e47. https://doi.org/10.3346/jkms.2027.42.e47

  • Open Access

    Life-threatening diffuse alveolar hemorrhage associated with Rhinovirus infection and the potential role of corticosteroids in immunocompetent patients

    byĀ Chang-Seok Yoon, Joon-Young Yoon, Bo-Gun Kho, Tae-Ok Kim, Yong-Soo Kwon, Yu-Il Kim, Sung-Chul Lim, Hong-Joon Shin

    Rationale: Diffuse alveolar hemorrhage (DAH) is a rare but potentially fatal condition characterized by bleeding into alveolar spaces, most often associated with autoimmune disease or severe infection. Rhinovirus is a common cause of upper respiratory tract infection but is rarely associated with DAH in immunocompetent individuals. We report 2 cases of life-threatening DAH associated with rhinovirus infection, both presenting with severe hypoxemia and showing marked improvement following corticosteroid therapy. Patient concerns: Case 1: An 85-year-old woman presented with massive hemoptysis, dyspnea, and hypoxemia. Chest computed tomography (CT) revealed diffuse ground-glass opacities (GGOs) and patchy consolidations. Case 2: A 70-year-old woman developed worsening dyspnea and hemoptysis despite antibiotics. She was hypoxemic, and chest CT showed bilateral GGOs and consolidations. Diagnoses: Bronchoalveolar lavage fluid demonstrated progressively hemorrhagic aliquots consistent with DAH in both cases. Multiplex viral polymerase chain reaction identified rhinovirus as the sole pathogen in both cases, and autoimmune serologic tests were negative. Interventions: Both patients received high-flow oxygen therapy, empirical antibiotics, and systemic corticosteroids (Case 1: intravenous methylprednisolone 1 mg/kg/day; Case 2: intravenous methylprednisolone 500 mg/day for 3 days, followed by tapering). Outcomes: After corticosteroid therapy, both patients showed rapid clinical and radiographic improvement, with resolution of hypoxemia and discharge within 10 days. Lessons: These cases suggest a potential association between rhinovirus infection and life-threatening DAH in immunocompetent patients. Both patients showed marked clinical improvement after corticosteroid therapy, suggesting a potential therapeutic role for systemic corticosteroids. Thus, clinicians should consider rhinovirus infection as a possible infectious trigger of DAH, and systemic corticosteroids may be considered in selected severe cases.

  • Predictors of Extended Treatment Duration in Drug-Susceptible Pulmonary Tuberculosis: A Multicenter Prospective Cohort Study

    byĀ Bo Gun Kho, Hong-Joon Shin, Yong-Soo Kwon

    This study aimed to identify factors associated with extended treatment for patients with drug-susceptible tuberculosis (TB). A prospective cohort study was involving patients with drug-susceptible TB who received a standard short-course regimen and achieved treatment success at the end of treatment from 18 institutions across the Republic of Korea. Patients were categorized based on their treatment duration: those treated for less than 200 days (standard treatment group) and those treated for more than 200 days (extended treatment group). Of 854 patients, there were 520 patients (60.9%) in the standard treatment group and 334 patients (39.1%) in the extended treatment group. A higher proportion of patients in the extended treatment group had DM, a history of TB treatment, multi-lobar involvement, and cavity lesions on chest radiography. This group also showed higher rates of positive AFB smear, leukopenia due to anti-TB medications, treatment interruption more than 7 days due to any reason and treatment interruption due to adverse drug reactions. Binary logistic regression revealed that DM (OR: 1.50, CI: 1.03–2.17, P = 0.03), a history of previous TB (OR: 3.14, CI: 2.01–4.89, P < 0.01), cavity lesions on chest radiography (OR: 3.06, CI: 2.01–4.67, P < 0.01), AFB smear positivity (OR: 4.39, CI: 2.98–6.46, P < 0.01), treatment interruption more than 7 days (OR: 4.74, CI: 2.66–8.46, P < 0.01), and leukopenia due to anti-TB medications (OR: 1.73, CI: 1.10–2.75, P = 0.02) were significant predictors of extended treatment. This study identified key factors associated with extended treatment for drug-susceptible TB in the Republic of Korea, emphasizing the need for targeted interventions and enhanced monitoring to optimize treatment outcomes.

  • Open Access

    A Deep Learning-Based Prediction Model for Mortality in Severe COVID-19 Patients Requiring Intensive Care Unit Admission: A Multicenter Registry Analysis

    byĀ Chang-Seok Yoon, Hong-Joon Shin, Bo-Gun Kho, Sunghoon Park, Su Hwan Lee, Onyu Park, Taehwa Kim, Hye Ju Yeo, Woo Hyun Cho, Chul Park, et al.

    Yoon CS, et al. J Korean Med Sci. 2026 Nov;41:e275. https://doi.org/10.3346/jkms.2026.41.e275

  • Open Access

    Impact of medical crisis on the critical care system in South Korea

    byĀ Ye Rim Chang, Jae Hwa Cho, Joongbum Cho, Tae Sun Ha, Bo Gun Kho, Eunhye Kim, Im-Kyung Kim, Dong Hyun Lee, Suk-Kyung Hong

    Background: The ongoing medical crisis in Korea has severely impacted the operational environment of intensive care units (ICU), posing significant challenges to quality care for critically ill patients. This study aimed to evaluate the effects of the ongoing crisis on ICUs. Methods: A survey was conducted in July 2024 among intensivists in charge of ICUs at institutions accredited by the Korean Society of Critical Care Medicine for critical care. The survey compared data from January 2024 (pre-crisis) and June 2024 (post-crisis) on the number ICU beds, staffing composition, work hours, and the number and roles of nurse practitioners. Results: Among the total of 71 participating ICUs, 22 experienced a reduction in the number of operational beds, with a median decrease of six beds per unit, totaling 127 beds across these ICUs. The numbers of residents and interns decreased from an average of 2.3 to 0.1 per ICU, and the average weekly working hours of intensivists increased from 62.3 to 78.8 hours. Nurse practitioners helped fill staffing gaps, with their numbers rising from 150 to 242 across ICUs, and their scope of practice expanded accordingly.Conclusions: The medical crisis has led to major changes in the critical care system, including staffing shortages, increased workloads, and an expanded role for nurse practitioners. This is a critical moment to foster interest and engage in active discussions aimed at creating a sustainable and resilient ICU system.


  • Open Access

    One-year mortality and readmission risks following hospitalization for acute exacerbation of chronic obstructive pulmonary disease based on the types of acute respiratory failure: An observational study

    byĀ Jang Hyeon Kim, Bo-Gun Kho, Chang-Seok Yoon, Young-Ok Na, Jae-Kyeong Lee, Ha-Young Park, Tae-Ok Kim, Yong-Soo Kwon, Yu-Il Kim, Sung-Chul Lim, et al.

    Few studies have examined the risk factors associated with the type of acute respiratory failure (ARF) in patients with acute exacerbation of chronic obstructive pulmonary disease (COPD). This study evaluated the clinical characteristics and prognosis of patients hospitalized for acute exacerbation of COPD based on the type of ARF. The medical charts of hospitalized patients with acute exacerbation of COPD between 2016 and 2021 were retrospectively reviewed. We classified ARF into 2 types: type 1 ARF with PaO 2 < 60 mm Hg in room air or a ratio of arterial partial pressure to fractional inspired oxygen < 300, and type 2 ARF with PaCO 2 > 45 mm Hg and arterial pH < 7.35. A total of 435 patients were enrolled in study, including 170 participants without ARF, 165 with type 1 ARF, and 100 with type 2 ARF. Compared with the non-ARF group, the frequency of high-flow nasal cannula, noninvasive ventilation, intensive care unit admissions, and in-hospital deaths was higher in the ARF group compared with the non-ARF group. The ARF group had higher 1-year mortality group (hazard ratio [HR], 2.809; 95% confidence interval [CI], 1.099–7.180; P = .031) and readmission within 1-year rates (HR, 1.561; 95% CI, 1.061–2.295; P = .024) than the non-ARF group. The type 1 ARF group had a higher risk of 1-year mortality (HR, 3.022; 95% CI, 1.041–8.774; P = .042) and hospital readmission within 1-year (HR, 2.053; 95% CI, 1.230–3.428; P = .006) compared with the non-ARF group. There was no difference in mortality and readmission rates between the type 1 and type 2 ARF groups. In conclusion, patients with type 1 ARF rather than type 2 ARF had higher mortality and readmission rates than those without ARF. The prognoses of patients with type 1 and type 2 ARF were similar.


  • Multigradient Siamese Temporal Model for the Prediction of Clinical Events in Rapid Response Systems

    byĀ Trong-Nghia Nguyen, Soo-Hyung Kim, Bo-Gun Kho, Hyung-Jeong Yang

    Early identification of emergency situations for intensive care unit (ICU) patients is a critical component of precision medicine. We present a Multi-gradient Siamese Temporal (MG-SiameseTS) model to predict patients’ clinical status within an 8-h window and trigger an alarm when anticipating an emergent situation. It incorporates gradient extractors, contrastive learning, focal loss, and imbalanced loss to address challenges related to bias, data quality, and interpretability. Experimental results using a practical dataset collected from the rapid response team at Chonnam National University Hospital in Korea demonstrate that the MG-SiameseTS model exhibits superior predictive capabilities for clinical events compared to several state-of-the-art methods.


  • One-year mortality and readmission rate following hospitalization for acute exacerbation of chronic obstructive pulmonary disease based on the types of acute respiratory failure

    byĀ Bo Gun Kho, Young-Ok Na, Jae-Kyeong Lee, Tae-Ok Kim, Yong-Soo Kwon, Yu-Il Kim, Sung-Chul Lim, Hong-Joon Shin

    Aims and objectives: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) can cause acute respiratory failure (ARF) and death. We retrospectively analyzed for 1-year mortality and readmission rate according to the type of ARF in hospitalized patients for AECOPD. Methods: We retrospectively reviewed the medical charts of hospitalized patients with COPD between 2016 and 2021 at two tertiary referral hospitals and ascertained the presence of ARF within 24 hours after admission. ARF was classified as type 1 (hypoxemic) and type 2 (hypercapnic). Results: In total, 435 patients were enrolled, of which 170 had no ARF, 165 had type 1 ARF, and 100 had type 2 ARF. As compared with non-ARF group, the frequency of use of high-flow nasal cannula, non-invasive ventilation, steroids, intensive care unit (ICU) admissions, and in-hospital deaths was higher for those with ARF. Compared to type 1 ARF group, type 2 ARF group required more non-invasive ventilation use, and ICU admission. The type 1 ARF group had a 2.8-fold of 1-year mortality (hazard ratio [HR], 2.80; 95% confidence interval [CI], 1.09-7.18; P=0.031) and 1.6-fold higher risk of hospital readmission rate within 1 year after discharge (HR, 1.62; 95% CI, 1.076-2.46; P=0.021) compared with the non-ARF group. Conclusions: Severe AECOPD patients with ARF had worse clinical outcomes than those without ARF. In particular, patients with type 1 ARF has a higher 1-year mortality and readmission rate than those without ARF.

  • The error rate of phenotypic drug susceptibility tests in tuberculosis patients according to specimen type.

    byĀ Bo Gun Kho, Young-Ok Na, Jae-Kyeong Lee, Tae-Ok Kim, Hong-Joon Shin

    Aims and objectives: A phenotypic drug susceptibility test (pDST) is the standard method for determining Mycobacterium tuberculosis (MTB) drug susceptibility. However, TB treatment can be complicated by errors in pDST. We evaluated the differences in pDST error rates based on the types of samples. Methods: We retrospectively reviewed medical records of patients diagnosed with tuberculosis in a single tertiary hospital for three years. Patients with at least one cultured MTB and pDST were included. NTM mixed culture, insufficient growth of control medium, and strain contamination were defined as pDST errors. Results: During the study period, 503 samples were collected from 447 patients. There were 282 men (61.4%) and an average age of 60.9 years. Among the samples collected, there were 354 samples of sputum (77.9%), 79 samples of washing (14.7%), 11 samples of lung tissues (2.4%), 8 samples of pleural fluid (1.6%), and 5 samples from other sources (1.2%). There were pDST errors in 44 samples (8.7%) of 36 patients. Mixed cultures with NTM were found in 18 cases, insufficient control medium growth was found in 17, and strain contamination was found in 9 cases. pDST error rates were higher in sputum samples than in non-sputum samples (9.7% vs. 5.4%; P = 0.186). In 36 patients with errors, 12 had performed additional pDSTs more than once. Five of them found no additional errors. Despite successful treatment for tuberculosis, two patients relapsed, and all were multidrug-resistant. Conclusion: The error rate of pDST varied according to the cultured TB specimens. Whenever errors occur, it is necessary to check pDST repeatedly.

  • Impact of COVID 19 and MRAB infection on mortality in ICU

    byĀ Bogun Kho, Hong-Joon Shin

    It is known that 3 – 5% of COVID 19 patients require critical care, and the mortality of patients receiving ventilator care is known to range from 50 to 97%. A study conducted in India found that secondary infection was associated with morality in COVID-19 patients. In this study, we compared the death rate of patients admitted to an intensive care unit before and after COVID 19 to find out the effect of Acinetobacter baumani and COVID 19 infection on death. A.baumanii infection, ventilator, charlson comorbidity index(CCI) , death, and earliest survival date were analyzed for 549 patients admitted to the intensive care unit in 2019 and 2020 and 71 patients admitted to the intensive care unit in 2021. Those who stayed in the ICU for less than 2 days were excluded from the analysis. Divided into pre- and post-epidemic periods of COVID 19, there was no statistical difference in ventilator application, A.baumanii identification, and mortality before and after the COVID19 epidemic (344/549 vs 41/71, p=0.422; 96/549, 14/71, p=0.64; 190/359 vs 23/48, p=0.711). When only patients who underwent ventilator treatment were selected and analyzed, there was no difference in A.baumanii identification or death (82/344, 14/41, p=0.149), but a statistically significant difference in CCI was shown. (1.3/0.37 p<0.001) When survival analysis was performed on patients treated with a ventilator, the 60-day survival rate was 57.1% in the covid-19 negative group, whereas the 60-day survival rate was 35.1% in the COVID 19-positive group, which was statistically significantly lower. (p=0.01). There was no association between COVID 19 and A.baumanii infection. But COVID19 infection is an important risk factor for death in ventilator-applied patients